Faron Pharmaceuticals Oy (FARN) Competitors GBX 185 -4.85 (-2.55%) As of 12:47 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock FARN vs. OXB, ERGO, SLN, PRTC, HZD, AVCT, VRP, ARIX, CIR, and BVXPShould you be buying Faron Pharmaceuticals Oy stock or one of its competitors? The main competitors of Faron Pharmaceuticals Oy include Oxford Biomedica (OXB), Ergomed (ERGO), Silence Therapeutics (SLN), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Avacta Group (AVCT), Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), Circassia Group (CIR), and Bioventix (BVXP). These companies are all part of the "biotechnology" industry. Faron Pharmaceuticals Oy vs. Its Competitors Oxford Biomedica Ergomed Silence Therapeutics PureTech Health Horizon Discovery Group plc (HZD.L) Avacta Group Verona Pharma plc (VRP.L) Arix Bioscience Circassia Group Bioventix Oxford Biomedica (LON:OXB) and Faron Pharmaceuticals Oy (LON:FARN) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership. Do analysts recommend OXB or FARN? Oxford Biomedica currently has a consensus price target of GBX 593.67, indicating a potential downside of 6.81%. Given Oxford Biomedica's stronger consensus rating and higher probable upside, research analysts clearly believe Oxford Biomedica is more favorable than Faron Pharmaceuticals Oy.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oxford Biomedica 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Faron Pharmaceuticals Oy 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger earnings and valuation, OXB or FARN? Faron Pharmaceuticals Oy has lower revenue, but higher earnings than Oxford Biomedica. Oxford Biomedica is trading at a lower price-to-earnings ratio than Faron Pharmaceuticals Oy, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOxford Biomedica£151.21M5.06-£143.51M-£0.36-1,758.85Faron Pharmaceuticals OyN/AN/A-£60.23M-£0.27-685.19 Does the media refer more to OXB or FARN? In the previous week, Faron Pharmaceuticals Oy had 2 more articles in the media than Oxford Biomedica. MarketBeat recorded 2 mentions for Faron Pharmaceuticals Oy and 0 mentions for Oxford Biomedica. Faron Pharmaceuticals Oy's average media sentiment score of 0.97 beat Oxford Biomedica's score of 0.00 indicating that Faron Pharmaceuticals Oy is being referred to more favorably in the news media. Company Overall Sentiment Oxford Biomedica Neutral Faron Pharmaceuticals Oy Positive Do institutionals and insiders have more ownership in OXB or FARN? 32.4% of Oxford Biomedica shares are held by institutional investors. Comparatively, 2.9% of Faron Pharmaceuticals Oy shares are held by institutional investors. 41.9% of Oxford Biomedica shares are held by company insiders. Comparatively, 4.1% of Faron Pharmaceuticals Oy shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is OXB or FARN more profitable? Faron Pharmaceuticals Oy has a net margin of 0.00% compared to Oxford Biomedica's net margin of -145.98%. Faron Pharmaceuticals Oy's return on equity of 0.46% beat Oxford Biomedica's return on equity.Company Net Margins Return on Equity Return on Assets Oxford Biomedica-145.98% -202.50% -12.67% Faron Pharmaceuticals Oy N/A 0.46%-70.00% Which has more volatility and risk, OXB or FARN? Oxford Biomedica has a beta of 1.09, suggesting that its stock price is 9% more volatile than the S&P 500. Comparatively, Faron Pharmaceuticals Oy has a beta of 0.36, suggesting that its stock price is 64% less volatile than the S&P 500. SummaryOxford Biomedica beats Faron Pharmaceuticals Oy on 8 of the 15 factors compared between the two stocks. Get Faron Pharmaceuticals Oy News Delivered to You Automatically Sign up to receive the latest news and ratings for FARN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FARN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FARN vs. The Competition Export to ExcelMetricFaron Pharmaceuticals OyBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£207.12M£233.54M£6.15B£2.60BDividend YieldN/A3.80%5.64%5.29%P/E Ratio-685.1994.6985.664,449.24Price / SalesN/A6,043.12527.3699,975.35Price / Cash20.0013.1926.3027.90Price / Book0.09113.9212.928.35Net Income-£60.23M-£90.99M£3.30B£5.89B7 Day Performance5.71%5.78%4.80%0.99%1 Month Performance-8.19%8.77%8.11%6.24%1 Year Performance-15.95%643.80%75.85%158.61% Faron Pharmaceuticals Oy Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FARNFaron Pharmaceuticals OyN/AGBX 185-2.6%N/A-13.7%£207.12MN/A-685.1934Gap DownHigh Trading VolumeOXBOxford Biomedica0.907 of 5 starsGBX 599.81+1.7%GBX 593.67-1.0%+59.2%£720.86M£151.21M-1,436.67891ERGOErgomedN/AN/AN/AN/A£701.00M£152.09M4,641.386SLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumePRTCPureTech Health2.5682 of 5 starsGBX 140.80+1.3%GBX 455+223.2%-5.9%£340.29M£6.17M828.24300Positive NewsHZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416AVCTAvacta Group2.1198 of 5 starsGBX 62.50+1.6%GBX 99+58.4%+41.8%£251.10M£113K-407.43120Earnings ReportVRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap UpARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.919CIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap DownBVXPBioventixN/AGBX 2,455+0.2%N/A-39.0%£128.27M£13.66M1,657.4412 Related Companies and Tools Related Companies Oxford Biomedica Alternatives Ergomed Alternatives Silence Therapeutics Alternatives PureTech Health Alternatives Horizon Discovery Group plc (HZD.L) Alternatives Avacta Group Alternatives Verona Pharma plc (VRP.L) Alternatives Arix Bioscience Alternatives Circassia Group Alternatives Bioventix Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:FARN) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredIs This Warren’s Buffett’s #1 AI Investment?Did you know that Warren Buffett is investing in what Jeff Brown believes will be the next generation of artif...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredWall Street legend: “Sell this A.I. stock now”Whats next after AI? Hidden AI. "Hidden AI" could soon be the biggest investment trend of 2025.Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Faron Pharmaceuticals Oy Please log in to your account or sign up in order to add this asset to your watchlist. Share Faron Pharmaceuticals Oy With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
